4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001584759-26-000017
Director sold 6,700 shares at $12.91 ($86,524)
- Director acquired 3,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Heyman Richard A. Director | 2026-10-01 | Option exercise 10b5-1 | +3,500 | $1.60 | $5,600 | 41,800 | D: show line 1 in the form |
| Heyman Richard A. Director | 2026-10-01 | Sale 10b5-1 | −3,500 | $12.91 | $45,199 | 38,300 | D: show line 2 in the form |
| Heyman Richard A. Director | 2026-10-01 | Sale 10b5-1 | −3,200 | $12.91 | $41,325 | 203,472 | I: show line 3 in the form |
| Open-market sales · 6,700 sh · avg $12.91 · $86,524 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Heyman Richard A. Director | 2026-10-01 | Option exercise · Stock Option (right to buy) 10b5-1 | −3,500 | 26,700 | D: show line 4 in the form |
Loading xslF345X06/form4-10022026_091044.xml…